Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6673
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents ; volume:13 ; number:1 ; day:25 ; month:5 ; year:2018 ; pages:1-8 ; date:12.2018
Journal of occupational medicine and toxicology ; 13, Heft 1 (25.5.2018), 1-8, 12.2018
- Creator
-
Westermann, Claudia
- Contributor
-
Wendeler, Dana
Nienhaus, Albert
SpringerLink (Online service)
- DOI
-
10.1186/s12995-018-0197-6
- URN
-
urn:nbn:de:101:1-2018080515403227319331
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Westermann, Claudia
- Wendeler, Dana
- Nienhaus, Albert
- SpringerLink (Online service)
Other Objects (12)
Hepatitis C in healthcare personnel: follow-up analysis of treatments with direct-acting antiviral agents
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study
HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)
Acute reversible rhabdomyolysis during direct-acting antiviral hepatitis C virus treatment: a case report
Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C
Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study
The role of a hepatitis C virus vaccine: modelling the benefits alongside direct-acting antiviral treatments
Utility of the new cobas HCV test for viral load monitoring during direct-acting antiviral therapy
Hepatitis C in healthcare personnel: follow-up analysis of treatments with direct-acting antiviral agents
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study
HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)
Acute reversible rhabdomyolysis during direct-acting antiviral hepatitis C virus treatment: a case report
Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C
Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study
The role of a hepatitis C virus vaccine: modelling the benefits alongside direct-acting antiviral treatments
Utility of the new cobas HCV test for viral load monitoring during direct-acting antiviral therapy
Hepatitis C in healthcare personnel: follow-up analysis of treatments with direct-acting antiviral agents
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study
HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)
Acute reversible rhabdomyolysis during direct-acting antiviral hepatitis C virus treatment: a case report
Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C
Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study
The role of a hepatitis C virus vaccine: modelling the benefits alongside direct-acting antiviral treatments